Company Analysis GoodRx Holdings, Inc.
1. Summary
Advantages
- Current debt level 41.71% is below 100% and has decreased over 5 years from 183.82%.
- The company's current efficiency (ROE=-1.16%) is higher than the sector average (ROE=-82.41%)
Disadvantages
- Price (4.65 $) is higher than fair price (0.163 $)
- Dividends (0%) are below the sector average (1.3%).
- The stock's return over the last year (-29.44%) is lower than the sector average (-15.35%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| GoodRx Holdings, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -9.4% | -13.8% | -1.4% |
| 90 days | -4.3% | -16.1% | -1.8% |
| 1 year | -29.4% | -15.3% | 16.7% |
GDRX vs Sector: GoodRx Holdings, Inc. has significantly underperformed the "Healthcare" sector by -14.09% over the past year.
GDRX vs Market: GoodRx Holdings, Inc. has significantly underperformed the market by -46.13% over the past year.
Stable price: GDRX is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: GDRX with weekly volatility of -0.5661% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (4.65 $) is higher than the fair price (0.163 $).
Price is higher than fair: The current price (4.65 $) is 96.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (336) is higher than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (336) is higher than that of the market as a whole (73.51).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.47) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (3.47) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.52) is lower than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (3.52) is lower than that of the market as a whole (15.92).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (16.43) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (16.43) is lower than that of the market as a whole (22.62).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -19.4% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-19.4%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (-1.16%) is higher than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (-1.16%) is lower than that of the market as a whole (25.01%).
5.5. ROA
ROA vs Sector: The company's ROA (-0.5582%) is lower than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (-0.5582%) is lower than that of the market as a whole (6.62%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.3%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 23.12.2021 | Bezdek Trevor Co-CEO |
Sale | 33.98 | 2 212 230 | 65 104 |
| 22.12.2021 | Bezdek Trevor Co-CEO |
Sale | 35.19 | 2 261 700 | 64 271 |
| 22.10.2021 | Slutsky Andrew President, Consumer |
Sale | 46.74 | 934 800 | 20 000 |
| 12.08.2021 | Slutsky Andrew President, Consumer |
Sale | 33 | 194 700 | 5 900 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
